MD HEALTHSHARES CORP
10QSB, 1998-09-03
HOME HEALTH CARE SERVICES
Previous: LASALLE PARTNERS INC, 8-K, 1998-09-03
Next: EQUITY OFFICE PROPERTIES TRUST, 8-K, 1998-09-03



<PAGE>
 
                      SECURITIES AND EXCHANGE COMMISSION
                            WASHINGTON, D.C.  20549

                                  FORM 10-QSB


[x]  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
       ACT OF 1934.

     For the quarterly period ended June 30, 1998.

[_]  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
       EXCHANGE ACT OF 1934.

     For the transition period from ------------ to ------------

     Commission file number:  0-22421


                          MD HealthShares Corporation
      -------------------------------------------------------------------
       (Exact Name of Small Business Issuer as Specified in Its Charter)

                      Louisiana                  72-1301480
             -------------------------------   -------------------
             (State or Other Jurisdiction of   (IRS Employer 
             Incorporation or Organization     Identification No.)

             12021 Bricksome Avenue, Baton Rouge, Louisiana  70816
             -----------------------------------------------------
                   (Address of Principal Executive Offices)

                                (225) 293-3272
               ------------------------------------------------
               (Issuer's Telephone Number, Including Area Code)


             ----------------------------------------------------
             (Former Name, Former Address and Former Fiscal Year,
                         if changed since Last Report)

Indicate by check mark whether the issuer:  (1) filed all reports required to be
filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the
past 12 months (or for such shorter period that the registrant was required to
file such reports), and (2) has been subject to such filing requirements for the
past 90 days.

Yes [_]  No [X]

State the number of shares outstanding of each of the issuer's common equity, as
of the latest practicable date:

As of June 30, 1998, 1,076,200 shares of the Registrant's Class A Non-Voting
Common Stock and 1 share of the Registrant's Class B Common Stock were
outstanding.

Transitional Small Business Disclosure Format (check one)   Yes [X]  No [_]
<PAGE>
                                    PART I
                             FINANCIAL INFORMATION

ITEM 1.   FINANCIAL STATEMENTS.

CONSOLIDATED BALANCE SHEETS
JUNE 30, 1998 AND DECEMBER 31, 1997 - UNAUDITED
- --------------------------------------------------------------------------------

                                                      JUNE 30,      DECEMBER 31,
                                                        1998           1997
ASSETS

CURRENT ASSETS:
  Cash and cash equivalents                          $ 1,072,823    $ 1,408,901
  Investments                                          4,259,440      4,840,825
  Interest receivable                                     56,593         55,095
  Premiums receivable                                     91,228         24,554
  Prepaid expenses                                       180,813         95,518
                                                     -----------    -----------
     Total current assets                              5,660,897      6,424,893

RESTRICTED INVESTMENTS                                 1,000,000      1,000,000

EQUIPMENT, net of accumulated depreciation of
  $23,128 in 1998 and $30,429, in 1997                    90,876         75,971

OTHER                                                     35,070         35,378
                                                     -----------    -----------
TOTAL                                                $ 6,786,843    $ 7,536,242
                                                     ===========    ===========

LIABILITIES AND STOCKHOLDERS' EQUITY

CURRENT LIABILITIES:
  Accounts payable and accrued expenses              $   159,609    $   122,268
  Claims payable and reserves for incurred 
   but unreported claims                                 774,746        145,131
  Deferred revenue                                           -            2,385
                                                     -----------    -----------
     Total current liabilities                           934,355        269,784
                                                     -----------    -----------

CONTINGENCIES (Note 2)

STOCKHOLDERS' EQUITY (Note 3):
  Junior preferred voting stock, $1.00 par value,
   liquidation value $1,000, 7,500 shares
   authorized, 2,154 shares issued and 
   outstanding in 1998; 2,152 in 1997                      2,154          2,152
  Preferred stock, $1.00 par value, 2,000,000  
   shares authorized, none issued and outstanding            -              -
   in 1998; and 1997
  Common stock:
   Class A non-voting, $0.10 par value, 8,000,000 
    shares authorized, 1,076,200 shares issued and 
    outstanding in 1998; 1,075,000 in 1997               107,620        107,500
   Class B, $0.10 par value, 1 share authorized
    and outstanding in 1998 and 1997                         -              -
  Additional paid-in capital                          11,757,900     11,732,023
  Accumulated deficit                                 (6,060,422)    (4,590,455)
  Treasury stock, at cost, 1,503 shares in 1998
    and 1997                                              (8,000)        (8,000)
  Unrealized gain on available-for-sale securities        53,236         23,238
                                                     -----------    -----------
     Total stockholders' equity                        5,852,488      7,266,458
                                                     -----------    -----------
TOTAL                                                $ 6,786,843    $ 7,536,242
                                                     ===========    ===========

See notes to consolidated financial statements.

<PAGE>
MD HEALTHSHARES CORPORATION

CONSOLIDATED STATEMENTS OF OPERATIONS
THREE AND SIX MONTH PERIODS ENDED JUNE 30, 1998 AND 1997 - UNAUDITED
- --------------------------------------------------------------------------------
<TABLE> 
<CAPTION> 
                                             THREE MONTHS ENDED           SIX MONTHS ENDED
                                                  JUNE 30,                    JUNE 30,
                                          ------------------------    ------------------------
                                              1998          1997          1998         1997
<S>                                      <C>          <C>            <C>          <C>
REVENUES:
  Premiums                                $   888,621  $    35,771    $ 1,574,796  $    37,081
  Investment income                           100,712      128,644        193,986      253,236
                                          -----------  -----------    -----------  -----------
     Total revenues                           999,333      164,415      1,768,782      290,317
                                          -----------  -----------    -----------  -----------
EXPENSES:
  Medical expenses                            751,255       30,765      1,334,502       31,891
  Selling, general and administrative       1,063,139      802,811      1,881,120    1,684,509
  Depreciation                                 14,714        4,224         23,128        6,554
                                          -----------  -----------    -----------  -----------
     Total expenses                         1,829,108      837,800      3,238,750    1,722,954
                                          -----------  -----------    -----------  -----------
NET LOSS                                  $  (829,775) $  (673,385)   $(1,469,968) $(1,432,637)
                                          ===========  ===========    ===========  ===========
NET LOSS PER COMMON
  SHARE                                   $     (0.77) $     (0.63)   $     (1.37) $     (1.34)
                                          ===========  ===========    ===========  ===========
AVERAGE OUTSTANDING
  COMMON SHARES                             1,076,200    1,071,001      1,076,200    1,071,001
                                          ===========  ===========    ===========  ===========

See notes to consolidated financial statements.
</TABLE> 
<PAGE>
<TABLE> 
<CAPTION> 
1998   1997
<S>                                                                       <C>              <C> 
CASH FLOWS FROM OPERATING ACTIVITIES:
  Net loss                                                                 $ (1,469,968)    $ (1,432,637)
  Adjustments to reconcile net loss to cash flows from
   operating activities:
    Depreciation                                                                 23,128            6,554
    Changes in operating assets and liabilities:
     Premiums receivable                                                        (66,674)          (2,163)
     Interest receivable                                                         (1,498)         (18,364)
     Prepaid expenses                                                           (85,295)         (63,093)
     Accounts payable and accrued expenses                                       37,341         (166,166)
     Claims payable and reserves for incurred but unreported claims             629,615           21,854
     Deferred revenue                                                            (2,385)          12,612
                                                                           ------------     ------------
       Net cash used in operating activities                                   (935,736)      (1,641,403)
                                                                           ------------     ------------

CASH FLOWS FROM INVESTING ACTIVITIES:
  Purchases of available-for-sale securities                                        -         (2,150,000)
  Sales and maturities of available-for-sale securities                         581,385        1,071,777
  Other                                                                             -            (58,036)
  Purchases of equipment                                                         (7,604)         (40,576)
                                                                           ------------     ------------
       Net cash used in investing activities                                    573,781       (1,176,835)
                                                                           ------------     ------------
CASH FLOWS FROM FINANCING ACTIVITIES:
  Proceeds from issuance of common stock                                         25,877              -
                                                                           ------------     ------------
NET DECREASE IN CASH                                                          (336,078)      (2,818,238)

CASH AND CASH EQUIVALENTS, Beginning of period                                1,408,901        9,147,525
                                                                           ------------     ------------
CASH AND CASH EQUIVALENTS, End of period                                   $  1,072,823     $  6,329,287
                                                                           ============     ============
NON-CASH INVESTING AND FINANCING TRANSACTIONS:
  Unrealized gain on available-for-sale securities                         $     29,997     $        -
                                                                           ============     ============
</TABLE> 

See notes to consolidated financial statements.

<PAGE>
 
MD HEALTHSHARES CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - UNAUDITED
- -------------------------------------------------------------------------------
1.   BASIS OF PRESENTATION

     The accompanying unaudited consolidated financial statements have been
     prepared in accordance with generally accepted accounting principles for
     interim financial information and with the instructions to Form 10-QSB and
     Rule 310(g) of Regulation S-B. Accordingly, they do not include all of the
     information and footnotes required by generally accepted accounting
     principles for complete financial statements. In the opinion of management,
     all adjustments (consisting of normal recurring accruals) considered
     necessary for fair presentation have been included. Operating results for
     the three month period ended June 30, 1998 are not necessarily indicative
     of the results that may be expected for the year ending December 31, 1998.

     RESERVES FOR INCURRED BUT UNREPORTED CLAIMS - The Company provides reserves
     for estimated incurred but unreported physician, hospital, and pharmacy
     services rendered to enrolled members during the period. These reserves are
     presently based on the use of estimated medical cost ratios. Changes in
     these estimates could be significant.

     REVENUE RECOGNITION - Premium revenues are recognized in the period in
     which the members are entitled to health care services. Premiums collected
     in advance are deferred, (consistent with industry practice, third-party
     selling expenses are reported as a reduction of premium revenue.)

     REINSURANCE - The Company is covered under a medical reinsurance agreement
     that generally provides coverage for 80% of hospital services in excess of
     $50,000 per member per year, up to a yearly maximum of $1,000,000 per
     member. There were no reinsurance recoveries in 1998 and 1997.

     RISKS AND UNCERTAINTIES - The Company's business could be impacted by
     continuing price pressure on new and renewal business, the Company's
     ability to effectively control health care costs, additional competitors
     entering the Company's markets, federal and state legislation in the area
     of health care reform, and governmental licensing regulations of HMOs and
     insurance companies. Changes in these areas could adversely impact the
     Company's operations in the future.

     FINANCIAL PRESENTATION - Certain reclassifications have been made to prior
     period amounts to conform with current period presentation.

     For a summary of other significant accounting policies, refer to Note 1 of
     Notes to Consolidated Financial Statements included in the Company's annual
     report on Form 10KSB for the year ended December 31, 1997.

2.   RECAPITALIZATION

     On March 22, 1997, the Company's stockholders approved a plan of
     recapitalization and amendments to the Company's articles of incorporation.
     In connection therewith, 7,500 shares of Junior Preferred Voting Stock,
     2,000,000 shares of Preferred Stock and 8,000,000 shares of Class A Non-
     Voting Stock were authorized. Additionally, all of the Company's 2,142
     outstanding shares of Class A Common Stock were cancelled, and each former
     share of Class A Common Stock was converted into one share of Junior
     Preferred Voting Stock and 500 shares of Class A Non-Voting Common Stock.
     The average number of outstanding common shares has been restated to
     reflect the recapitalization.
<PAGE>
 
3.   COMMITMENTS AND CONTINGENCIES

     RESTRICTED INVESTMENTS - In connection with the filing for a COA, and as an
     ongoing requirement of the State of Louisiana, PCI has deposited with the
     Commissioner a safe keeping receipt of $1,000,000, consisting of
     certificates of deposits in ten separate banking corporations doing banking
     business within the State of Louisiana.

     REGULATORY REQUIREMENTS The State of Louisiana has implemented financial
     regulations for HMOs requiring, among other things, minimum net worth
     requirements. As of December 31, 1997, admitted assets, as defined, less
     liabilities, must be at least equal to $1,500,000 as reported in the
     statutory filing of such calendar year. PCI was in compliance with the
     state statutory net worth requirement at December 31, 1997 and June 30,
     1998. The minimum state statutory net worth requirement will increase to
     $2.0 million on July 1, 1998.

4.   STOCKHOLDERS' EQUITY

     During the first quarter, the Company sold three units of capital stock
     which were comprised of three shares of Junior Preferred Voting Stock and
     1,200 shares of Class A Non-Voting Common Stock. The average number of
     outstanding common shares for the quarter reflects these transactions.

ITEM 2.  MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATION

     The Company continued its focus on developing the infrastructure of its
     managed care subsidiary company, Patient's Choice. Additional professional
     staff with experience in managed care was retained. Network development
     remained an ongoing activity as selected hospitals, physician groups, and
     ancillary service providers were targeted for contracting in an effort to
     create highly marketable networks. The Medical Affairs Department continued
     its development and refinement of medical guidelines, employing specialty
     advisory work groups to review and refine currently available medical
     guidelines. The Company initiated a search for appropriate claims
     processing and data collection systems with the intent of bringing this
     function in-house by the end of the year.

     The sales and marketing staff continued to focus its energies on larger
     employed groups. The Company has answered numerous RFPs from public
     agencies and private employers. Most of these proposals are for managed
     care services beginning in January 1998, and prospects for obtaining some
     of these contracts appear to be encouraging. As of September 1, 1998,
     Patient's Choice has contracted with 130 groups to provide health care
     coverage for 1,360 subscribers, and 2,597 covered lives in its HMO and
     Point of Service plans.

     The Company incurred during the second quarter of 1998 and has incurred
     since the inception of operations in the first quarter of 1997 substantial
     losses from operations due to the lack of premium income resulting from
     delays in marketing its managed care plans. The Company anticipates that
     such losses will continue until the number of enrollees in the Company's
     health plans increases and premium income exceeds administrative expenses
     and claims payments. While there is no assurance that the Company has
     sufficient capital to fund these losses or that it will achieve enough
     enrollees to support profitable operations, the Company does not anticipate
     the need to raise additional capital during the next twelve months.

     Certain statements, other than statements of historical fact, contained in
     this Quarterly Report on Form 10-QSB are forward-looking statements as
     defined in the Private Securities Litigation Reform Act of 1995. These
     forward-looking statements are generally accompanied by such terms and
     phrases as "anticipates", "estimates", "expects", "believes", "should",
     "projects", "scheduled", or similar 
<PAGE>
 
     statements. The Company believes that the expectations reflected in such
     forward-looking statements are reasonable, however it can give no assurance
     that such expectations will prove correct. All forward-looking statements
     in this Form 10-QSB are expressly qualified in their entry by the
     cautionary statements in the paragraph.

     The Company has reviewed its year 2000 compliance status and has determined
     that all systems are sufficient except for one software package that will
     be replaced effective January 1, 1999. The cost of this replacement will be
     minimal.
<PAGE>
 
                                    PART II
                               OTHER INFORMATION

ITEM 6.  EXHIBITS AND REPORTS ON FORM 8-K.

     (a) Reports of Form 8-K. No reports on Form 8-K were filed during the three
         -------------------                                                    
         months ended June 30, 1998.


                                   SIGNATURES

In accordance with the requirements of the Exchange Act, the registrant caused
this report to be signed on its behalf by the undersigned, thereunto duly
authorized.


                          MD HEALTHSHARES CORPORATION

Date:  September 3, 1998      /s/  Patrick C. Powers
                                   --------------------------------
                                            Patrick C. Powers
                                            Chief Executive Officer

Date:  September 3, 1998      /s/  Adam Short
                                   --------------------------------
                                            Adam Short
                                            Chief Financial Officer


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission